APA (7th ed.) Citation

Au, J. H., Hooper, P. B., Fitzgerald, A. L., & Somani, A. (2022). Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes when Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series. Dermatology & Therapy, 12(2), 591. https://doi.org/10.1007/s13555-021-00665-y

Chicago Style (17th ed.) Citation

Au, Jeremiah H., Perry B. Hooper, Alison L. Fitzgerald, and Ally-Khan Somani. "Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes When Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series." Dermatology & Therapy 12, no. 2 (2022): 591. https://doi.org/10.1007/s13555-021-00665-y.

MLA (9th ed.) Citation

Au, Jeremiah H., et al. "Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes When Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series." Dermatology & Therapy, vol. 12, no. 2, 2022, p. 591, https://doi.org/10.1007/s13555-021-00665-y.